UA has recently been shown to normalize AD-associated inflammation (Hou et al., 2024), and age-associated inflammation (Ignacio Jiménez-Loygorri et al., 2024) in mice, while significantly reducing C-reactive proteins in a human randomized trial via mitophagy stimulation (Singh et al., 2022). Here, CRP is linked to Alzheimer disease.